Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 210,000 | 195,000 | 156,000 | 196,000 | 237,000 |
| Receivables | 1,470,000 | 1,444,000 | 1,429,000 | 1,472,000 | 1,385,000 |
| Inventories | 1,077,000 | 1,023,000 | 971,000 | 955,000 | 998,000 |
| Income taxes - deferred | 76,000 | 75,000 | 65,000 | 75,000 | 84,000 |
| Other current assets | 645,000 | 485,000 | 405,000 | 541,000 | 477,000 |
| TOTAL | $3,478,000 | $3,222,000 | $3,026,000 | $3,239,000 | $3,181,000 |
| Non-Current Assets | |||||
| PPE Net | 1,678,000 | 1,651,000 | 1,652,000 | 1,630,000 | 1,500,000 |
| Intangibles | 12,665,000 | 12,792,000 | 12,423,000 | 12,561,000 | 12,336,000 |
| Other Non-Current Assets | 815,000 | 717,000 | 842,000 | 666,000 | 680,000 |
| TOTAL | $15,158,000 | $15,160,000 | $14,917,000 | $14,857,000 | $14,516,000 |
| Total Assets | $18,636,000 | $18,382,000 | $17,943,000 | $18,096,000 | $17,697,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,266,000 | 1,018,000 | 5,000 | 64,000 | 254,000 |
| Accounts payable and accrued liabilities | 371,000 | 376,000 | 376,000 | 447,000 | 298,000 |
| Accrued Expenses | 2,551,000 | 2,238,000 | 2,298,000 | 2,312,000 | 2,099,000 |
| Other current liabilities | 640,000 | 668,000 | 811,000 | 764,000 | 365,000 |
| TOTAL | $4,828,000 | $4,300,000 | $3,490,000 | $3,587,000 | $3,016,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,416,000 | 4,817,000 | 5,509,000 | 5,420,000 | 5,171,000 |
| Other Non-Current Liabilities | 1,738,000 | 1,972,000 | 1,872,000 | 2,338,000 | 3,002,000 |
| TOTAL | $6,220,000 | $6,847,000 | $7,400,000 | $7,776,000 | $8,199,000 |
| Total Liabilities | $11,048,000 | $11,147,000 | $10,890,000 | $11,363,000 | $11,215,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,373,196 | 1,372,127 | 1,369,402 | 1,363,489 | 1,361,677 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 19,000 |
| Retained earnings | -7,785,000 | -8,068,000 | -8,215,000 | -8,581,000 | -8,706,000 |
| Other shareholders' equity | -51,000 | -53,000 | -46,000 | 1,000 | -99,000 |
| TOTAL | $7,588,000 | $7,235,000 | $7,053,000 | $6,733,000 | $6,482,000 |
| Total Liabilities And Equity | $18,636,000 | $18,382,000 | $17,943,000 | $18,096,000 | $17,697,000 |